Cimarex Resolute (REN) Form 3 Initial statement of insider ownership

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Monarch Alternative Capital LP

(Last) (First) (Middle)

535 MADISON AVENUE, 26TH FLOOR

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/15/2018

3. Issuer Name and Ticker or Trading Symbol
Resolute Energy Corp [ REN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	70,868	I	See footnotes(1)(2)
Common Stock	543,931	I	See footnotes(1)(3)
Common Stock	452,297	I	See footnotes(1)(4)
Common Stock	862,721	I	See footnotes(1)(5)
Common Stock	338,254	I	See footnotes(1)(6)
Common Stock	329	I	See footnotes(1)(7)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Monarch Alternative Capital LP

(Last) (First) (Middle)

535 MADISON AVENUE, 26TH FLOOR

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

MDRA GP LP

(Last) (First) (Middle)

C/O MONARCH ALTERNATIVE CAPITAL LP

535 MADISON AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Monarch GP LLC

(Last) (First) (Middle)

C/O MONARCH ALTERNATIVE CAPITAL LP

535 MADISON AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

Explanation of Responses:

1. See Exhibit 99.1.

2. See Exhibit 99.1.

3. See Exhibit 99.1.

4. See Exhibit 99.1.

5. See Exhibit 99.1.

6. See Exhibit 99.1.

7. See Exhibit 99.1.

Remarks:

Joseph Citarrella, a Managing Principal of Monarch Alternative Capital LP, serves on the board of directors of the Issuer as a representative of Monarch Alternative Capital LP. As a result, each of Monarch Alternative Capital LP, and by virtue of their control of Monarch Alternative Capital LP, MDRA GP LP and Monarch GP LLC is a "director-by-deputization" solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Information and Signatures

	MONARCH ALTERNATIVE CAPITAL LP, By: /s/ Michael A. Weinstock, Chief Executive Officer	05/17/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.